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Abstract 
Information on the in vitro growth of pathogenic and non‑pathogenic Mycoplasma hyopneumoniae (M. hyopneumo-
niae) strains is scarce and controversial. Despite its limitations, the colour changing units (CCU) assay is still considered 
the golden standard titration technique for M. hyopneumoniae culture. Thus, the aims of the present study were: (1) 
to describe the growth dynamics and kinetics of pathogenic and non‑pathogenic M. hyopneumoniae strains, and (2) 
to monitor the strains’ daily growth by ATP luminometry, CCU, colony forming units (CFU), and DNA quantification 
by real time quantitative PCR (qPCR) and by fluorescent double‑stranded DNA (dsDNA) staining, to evaluate them as 
putative titration methodologies. The growth of the non‑pathogenic J (ATCC ®25934™) type strain and the pathogenic 
11 (ATCC ®25095™) reference strain and 232 strain was modelled by the Gompertz model. Globally, all three‑strain 
cultures showed the same growing phases as well as similar maximal titres within a particular technique, but for CFU. 
However, the J strain displayed the fastest growing. During the logarithmic phase of growing, CCU, ATP and M. hyo-
pneumoniae copy titres were strongly and linearly associated, and correlation between techniques could be reliably 
established. In conclusion, real‑time culture titration by means of ATP or molecular assays was useful to describe the 
in vitro growth of the tested strains. Knowledge about the in vitro growth behaviour of a specific strain in a specific 
medium may provide several advantages, including information about the time required to reach maximal titres by 
the culture. Noteworthy, the obtained results refers to the three strains used, so extrapolation to other M. hyopneumo-
niae strains or culture conditions should be made cautiously.
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and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
In 1965, Maré and Switzer in the United States and 
Goodwin in the United Kingdom isolated Mycoplasma 
hyopneumoniae (M. hyopneumoniae) strains 11 and J, 
respectively [1]. Since then, this bacterium has been 
reported to play a prominent role in pig respiratory dis-
eases [2]. Strain J was accepted as the type strain of M. 
hyopneumoniae [1]. Although originated from lung 
lesions and considered pathogenic, pneumonia was not 
reproduced when pigs were inoculated with this strain 
after several in vitro passages [3, 4]. From then, J strain 
was recognized as non-pathogenic. Additionally, some of 
the current commercial bacterins used to control enzo-
otic pneumonia are based on J strain [5]. On the other 
hand, M. hyopneumoniae strain 232, which was isolated 
from serially passaged porcine lung homogenate contain-
ing strain 11 [3], is widely used in experimental studies in 
the United States and has progressively substituted strain 
11 in multiple studies, though both are considered patho-
genic strains [3]. M. hyopneumoniae strain 11 is also used 
as inactivated whole cell concentrate for vaccination [6].
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Despite comparative genomic [7–9] and proteomic [10, 
11] analyses between M. hyopneumoniae strains have 
been made, little is still known on the in vitro growth of 
strains differing in pathogenicity and, by extension, in vir-
ulence. In addition, available information in this respect 
may result contradictory. On the one hand, a higher viru-
lence of M. hyopneumoniae has been associated with a 
faster in vitro growth [12], though this could not be cor-
roborated afterwards [13]. On the other hand, low-pas-
saged M. hyopneumoniae strains may grow slowly and 
may yield lower number of cells in medium than higher-
passaged strains, which, in turn, may not be virulent [3, 
14, 15]. In connection with this matter, non-pathogenic 
strains’ protein expression profile has been shown to be 
more related to metabolism than to infectiousness [10, 
11]. Therefore, the putative relationship between patho-
genicity and in vitro growing capacity of M. hyopneumo-
niae deserves further investigation.
Besides, outputs obtained from live animals inoculated 
with M. hyopneumoniae may vary considerably from one 
experiment to another [16–19]. Although many other 
factors might be involved, an inoculum dose-dependent 
response has been reported in these experiments [20]. 
Despite the well-known colour changing units (CCU) 
assay limitations in the assessment of the live M. hyo-
pneumoniae cell titres [13, 21], this technique continues 
to be the most frequently used to calculate the inoculum 
dose given to the animals under experimental settings. 
Indeed, ATP luminometry [13] and flow cytometry [21] 
assays have been proposed as more reliable, accurate and 
as real-time titration tools [13, 21]. Notwithstanding, 
none of these two techniques is specific for M. hyopneu-
moniae. Therefore, a deeper comparison of the CCU with 
other real-time, accessible and, if possible, M. hyopneu-
moniae-specific techniques remains of general interest.
The aims of the present work were twofold. Firstly, 
growth dynamics and kinetics of pathogenic (11 and 232) 
and non-pathogenic (J) strains M. hyopneumoniae  were 
described. Secondly, bacterium growth was monitored 
by different methodologies, including ATP luminometry, 
CCU and colony forming units (CFU), and molecular 
detection methods as real time quantitative PCR (qPCR) 
and fluorescent double-stranded DNA (dsDNA) stain-
ing, with the objective to evaluate them as putative tech-
niques for titration of M. hyopneumoniae culture.
Materials and methods
M. hyopneumoniae strains and medium for culturing
Type strain J (ATCC ®25934™) and strain 11(ATCC ®25095™) were obtained from the American Type Cul-
ture Collection (ATCC). Boehringer Ingelheim Vet-
erinary Research Center (BIVRC) GmbH & Co. KG 
(Hannover, Germany) kindly provided strain 232. All 
strains were grown in the ATCC recommended condi-
tions: ATCC medium for M. hyopneumoniae culture 
purposes (ATCC ® Medium 1699: Revised Mycoplasma 
medium) at 37 °C in an aerobic or 5%  CO2 atmospheres 
for broth and solid mediums, respectively.
Experimental design
In order to compare the growth curves of these three M. 
hyopneumoniae  strains, an initial inoculum of each of 
them was prepared from a single colony. Thus, a well-
shaped and well-separated colony of each strain was 
selected with the help of an optical microscope to local-
ize it on the plate. Thereafter, plates were opened under 
the laboratory hood and agar was punctured with a 
sterile 1000  μL size filter pipette tip and immediately 
resuspended in 1  mL of ATCC broth medium. After 
approximately 2  weeks of incubation, these cultures 
turned from red to orange to yellow and were then frozen 
at −80 °C until used. These frozen cultures were consid-
ered the initial inoculums.
For the experiment, M. hyopneumoniae strain (J, 11 
and 232) initial inoculums were thawed and 100-fold 
diluted in duplicates (named A and B) in a final volume 
of 45 mL of ATCC broth medium. A tube containing only 
45 mL of broth served as a control. Cultures were grown 
statically and followed up until the senescence phase was 
reached. Thus, once the initial inoculum dilutions were 
done, 2 vials of 1 mL each of every culture replicate and 
control were taken at day 0 post-culture inoculation (D0), 
at 12 h after (D0.5) and, afterwards, every 24 h until the 
end of the study (D14). In order to avoid cross-contami-
nation between M. hyopneumoniae strains, manipulation 
of each strain culture was performed in separate labora-
tory hoods. One vial of each duplicate was directly frozen 
at −20  °C whereas the other one was freshly and daily 
used for ATP luminometry, CFU and CCU titre assess-
ments. The frozen vial was used once the experiment was 
finished for genomic DNA extraction and M. hyopneu-
moniae copies calculation by real time quantitative PCR 
(qPCR) and fluorescent double-stranded nucleic acid 
stain.
CCU assay
Formerly described conditions were followed to assess 
the number of CCU [13] at every single time point. 
Briefly, tenfold serial dilutions (until  10−11) of each M. 
hyopneumoniae strain culture replicate in ATCC broth 
medium were done. Microtiter plates were then sealed 
with plastic foil, and incubated at 37 °C for 2 weeks. The 
CCU titre was determined from 2 repeated measure-
ments (A and B) per each strain culture (but for control) 
and expressed as mean CCU/mL.
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CFU assay
At every time point, solid medium plates were inoculated 
with each strain culture replicate. Plates were divided 
into eight equal parts. In each segment, a drop of 10 μL 
of either fresh undiluted culture or a tenfold serial dilu-
tion in ATCC broth medium (from  10−1 to  10−7) was 
spotted onto. In the case of the control, no dilutions were 
performed and the broth was directly spotted onto the 
plate. Drops were allowed to become air-dried under the 
laboratory hood and plates were covered and incubated 
for 7  days. By means of an optical microscope, M. hyo-
pneumoniae colonies were counted until the last dilution 
in which they were present. The counts of each two strain 
replicates (A and B) were considered and the mean CFU/
mL calculated.
ATP dependent luminometry assay
For luminometry, the BacTiter-Glo™ Microbial Cell Via-
bility assay (Promega, Madison, WI, USA) together with 
a Fluoroskan  Ascent® FL luminometer (Thermo Electron 
Inc., Milford, MA, USA) were used. For every time point 
measurement, 100 μL of freshly M. hyopneumoniae cul-
tures and control were taken and mixed with 100 μL Bac-
Titer-Glo™ reagent in white opaque 96-well microplates 
(PerkinElmer, Waltham, MA, USA). Directly after, the 
contents were mixed briefly by orbital shaking and incu-
bated at room temperature for 5 min. Luminescence was 
thereafter measured and recorded as relative light units 
(RLU). To transform RLUs into ATP concentrations, ten-
fold dilutions of r-ATP (Promega, Madison, WI, USA) in 
ATCC broth medium, from 10  µM to 1  nM, were used 
as standard. For each plate, sample results were adjusted 
by subtracting the mean RLUs of the blank (ATCC broth 
medium). ATP titres of each strain culture were deter-
mined as the mean of the replicate measurements (A 
and B) and expressed as pmol ATP/mL of culture of M. 
hyopneumoniae.
Genomic DNA extraction
DNA was extracted for every time point from 1  mL of 
broth culture of each strain replicate and control using 
GenElute™ Mammalian Genomic DNA Miniprep Kit 
(Sigma-Aldrich, Saint Louis, MO, USA). Once thawed, 
cultures and control were centrifuged at 10 000  g dur-
ing 2 min and the cell pellet was then resuspended with 
200 μL of the provided resuspension solution. DNA was 
eluted in 200 μL of elution buffer.
Fluorescent double‑stranded DNA stain assay
DsDNA content was determined using the Quan-iT™ 
 PicoGreen® dsDNA kit (Life Technologies, Eugene, OR, 
USA) together with a Fluoroskan  Ascent® FL fluorimeter 
(Thermo Electron Inc., Milford, MA, USA). Ten micro-
liter of the extracted DNA
from every time point and strain replicates and con-
trol was mixed with 190 μL of Quan-iT™ PicoGreen rea-
gent in white opaque 96-well microplates (PerkinElmer, 
Waltham, MA, USA). Afterwards, the contents were 
mixed briefly by orbital shaking and incubated at room 
temperature for 5  min. Fluorescence was then meas-
ured and recorded as relative fluorescence units (RFU). 
In order to convert RFUs into dsDNA concentrations, 
tenfold dilutions of the provided Lambda DNA standard 
in the elution buffer used for the DNA extraction (Gen-
Elute™ Mammalian Genomic DNA Miniprep Kit) were 
used to elaborate a standard curve (final concentrations 
from 500 to 0.5 ng/mL). Samples’ fluorescence value was 
adjusted by subtracting the mean RFU of the reagent 
blank (elution buffer). DsDNA concentration of each 
strain culture was obtained as the mean of the replicate 
measurements (A and B) and expressed as ng/mL. Such 
concentration was used thereafter for determining the M. 
hyopneumoniae copy numbers per mL in each template.
Real time quantitative PCR for M. hyopneumoniae
A previously described qPCR specific for M. hyopneumo-
niae was performed [22]. DNA extracted from cultures 
was used as template and plasmid as a standard for the 
qPCR development.  Since sensitivity of the aforesaid 
qPCR was reported to be between  103  and  104  M. hyo-
pneumoniae copies/mL of plasmid [22], all those sam-
ples with a bacterial load below  104 M. hyopneumoniae 
copies/mL were considered negative. QPCR results were 
expressed as the mean of M. hyopneumoniae copy num-
bers per mL of culture of the replicate measurements (A 
and B).
M. hyopneumoniae strains growth modelling
In order to quantitatively describe the in  vitro growth 
of M. hyopneumoniae strains, a non-linear asymp-
totic model, namely the Gompertz equation, was fit-
ted to each M. hyopneumoniae strain culture titre data 
obtained from the daily application of the different evalu-
ated methodologies. The Gompertz equation enables to 
calculate growth kinetic parameters, thereby allowing 
the comparison of these parameters between the differ-
ent techniques [23]. The aforesaid model was fitted to 
data with STATISTICA version 8.0 (Stat Soft, Inc., USA) 
and the equation used can be written in the form [24]: 
Y = A*(e(− B*e(− C*t))).
The dependent variable  Y represents the observed 
titre value at  a time (t); parameter  A  describes the titre 
value as it approaches infinity, though representing the 
maximal titre; parameter  B  is an integration constant 
Page 4 of 11Garcia‑Morante et al. Vet Res  (2018) 49:45 
defined as the proportion of the asymptotic maximal titre 
obtained after the initial inoculum dilution (established 
by the initial titre value and  t), and parameter  C equals 
the ratio between the maximum growth rate (μmax) and 
the maximal titres and determines the slope of the curve. 
Thus, μmax was obtained by multiplying A and C param-
eters. Considering M. hyopneumoniae as an asynchronic 
culture (i.e. cells of the total population do not divide 
simultaneously), mean generation time (G) was estimated 
by l/μmax as proposed by Baranyi and Roberts [25].
Model goodness of fit was evaluated according to the R2 
and the average prediction error (APE). The first deter-
mines the percentage of variation in Y explained by the 
statistical model whereas the latter quantifies the relative 
disagreement between observed (Y) and predicted (PY) 
titre values for each specific t and is calculated as follows: 
APE % = ([Y − PY]/Y) × 100 [26]. In order to evaluate the 
methodology from which the Gompertz growth model 
was better fitted to the data, mean APE per technique 
was calculated by averaging values obtained from each 
strain culture.
Statistical analyses were performed using STATISTICA 
version 8.0 (Stat Soft, Inc., USA). Differences between 
each M. hyopneumoniae strain mean value of the param-
eters obtained from the Gompertz modelling were tested 
for statistical significance by Kruskal–Wallis test (non-
parametric, one-way ANOVA) with post hoc multiple 
comparisons (Dunn’s multiple comparison test). Normal 
distribution and the constant variance were evaluated by 
the Shapiro–Wilk’s test and Levene’s test, respectively. p 
values < 0.05 were considered to be significant.
Relationship between assessed techniques
In order to compare the different assessed methodolo-
gies, a linear regression analysis between each pair of 
M. hyopneumoniae culture titration techniques was car-
ried out on the log2 transformed data during each strain 
maximal culture growth, namely logarithmic (log) phase. 
Thus, the period of study days compared was established 
taking into account the log phase duration from the 
growth response determined by the ATP assay in each 
strain culture. From such analysis, regression formulae 
were acquired to enable conversion of data (culture titre) 
obtained by means of different techniques. All statistical 
analyses were carried out using STATISTICA version 8.0 
(Stat Soft, Inc., USA). The significance level (p) was set 
at 0.05 with statistical tendencies reported when p < 0.10.
Results
Negative control (uninoculated ATCC broth medium) 
had similar ATP values and dsDNA fluorescence reac-
tions than the blank throughout the study (from D0 to 
D14). Additionally, no colonies were found in any of the 
agar plates inoculated, no colour change was detected 
at any time point and qPCR results were also negative. 
Unfortunately, a fungus-like contamination was detected 
in replicate A of M. hyopneumoniae J strain culture at 
D7. Therefore, from D7 onwards, different methodology 
titres were assessed for J strain culture only from the rep-
licate B. Microbial growth curves obtained for each strain 
and each technique were log2 transformed for the pur-
poses of graphic representation.
M. hyopneumoniae ATP growth response curves
The growth response determined by ATP for each of the 
three M. hyopneumoniae strains is represented in Fig-
ure 1. It is important to mention that ATP concentration 
levels between strain initial inocula after thawing were 
very similar (1222.1 ± 86.2 pmol ATP/mL), which verified 
that the growth dynamics was started from approximated 
equal conditions for each M. hyopneumoniae strain cul-
ture. By means of ATP luminometry, all strains showed 
growth curves with log, stationary and death phases, and 
culture colour change (from the original red to orange) 
firstly detected at the end of the logarithmic phase; when 
yellow, cultures were established in the stationary phase. 
M. hyopneumoniae J strain reached earlier the station-
ary phase than 11 and 232 strains. Nonetheless, the latter 
ones had longer stationary phases followed by less sharp 
senescence phases in comparison with J strain. Addition-
ally, all three evaluated strains reached similar maximal 
raw ATP concentrations (1395.5 ± 148.9  pmol ATP/mL) 
once in the stationary phase.
M. hyopneumoniae CCU growth response curves
The growth response determined by the CCU assay 
for each of the three M. hyopneumoniae strains is 
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Figure 1 ATP growth curves of M. hyopneumoniae strains 
J (filled triangle), 11 (filled square) and 232 (filled circle). 
Data points represent means of the 2 replicate ATP luminometry 
measurements (A and B) within each strain. The orange data points 
indicate when the original medium colour change was first visually 
detected in each strain culture.
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represented in Figure 2. In contrast to ATP luminometry, 
a lag phase was observed for J and 11 strains. Following 
such an initial phase, log, stationary and death phases 
could also be visually differentiated, although not as eas-
ily as with ATP concentration along time. Importantly, 
when all strain cultures colour shift was detected, CCU 
maximal titres were already reached. Similarly to ATP, 
all three evaluated strains reached similar maximal raw 
CCU titres (4.25 × 109 ± 1.30 × 109 CCU/mL) in the sta-
tionary phase. Those were also reached earlier by J strain, 
which again showed a shorter stationary phase than M. 
hyopneumoniae 11 and 232 strains.
Growth of M. hyopneumoniae on solid media
In this experiment, solid medium enabled the growth 
of M. hyopneumoniae J, 11 and 232 strains. Colonies from 
such three strains were phenotypically indistinguishable 
between them through microscopic visualization. Thus, 
end-point colonies ranged in size, from 100 to 240  µm, 
and were rough with irregular margin, normally lacking 
a clearly defined nipple (no “fried egg appearance”) (Fig-
ure 3). Colonies were observed as early as D3 for J strain 
and at D6 and D8 for 11 and 232 strains, respectively. 
The period of time in which colonies were observed var-
ied between 7 days for J, 3 for 11 and 2 for 232 strains. 
Hence, the growth curve using viable counts on the solid 
medium could only be determined by J strain. Since all 
the growth phases could be well established by means of 
ATP luminometry, counts of CFU per mL of M. hyopneu-
moniae  J strain to its ATP growth response along the 
study period is depicted in Figure 4.
Copies of M. hyopneumoniae genomic DNA determination
Mycoplasma hyopneumoniae genome copy numbers per 
mL of the three strain cultures assessed by the fluores-
cent dsDNA stain assay and qPCR are shown in Figures 5 
and 6, respectively. Both methodologies resulted in simi-
lar curves from which a lag and log phases could be rec-
ognised. However, the range of copy numbers assessed 
by qPCR was wider than the one assessed by fluorimetry. 
Once reached the maximal number of M. hyopneumo-
niae copies/mL, a slightly gradual decrease in the copy 
numbers was observed as time progressed, though sta-
tionary and senescence phases could not be differenti-
ated. Remarkably, the reach of the maximal number of M. 
hyopneumoniae copies/mL of culture concurred approxi-
mately in time with the maximal ATP values.
Growth kinetic parameters of M. hyopneumoniae
The Gompertz model could not be reliably applied to 
CFU titres because of the lack of data for 11 and 232 M. 
hyopneumoniae strains and the very short log phase 
as well as the lack of a stationary phase of the J strain 
growth curve. For all other techniques, the values of the 
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Figure 2 CCU growth curves of M. hyopneumoniae strains J 
(filled triangle), 11 (filled square) and 232 (filled circle). Data 
points represent means of the 2 replicate CCU assay measurements 
(A and B) within each strain. The orange data points indicate when 
the original medium colour change was first visually detected in each 
strain culture.
Figure 3 Colonies of M. hyopneumoniae J strain on solid media. Colonies were photographed at 5 days post‑inoculation (D5) of A undiluted 
culture, B  10−1 and C  10−2 dilution of the culture in ATCC medium. In B, the limit of the culture drop can be differentiated with the colonies 
observed within such limit. Once inoculated, solid plates were incubated for 7 days at 37 °C and 5%  CO2 and photographed using a microscope at 
×40.
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parameters estimated for the Gompertz model are shown 
in Table 1. All three strains had close values for param-
eters A and B in each of the evaluated techniques but 
for qPCR, in which significant differences between 11 
and 232 strains were observed. Remarkably, the kinetic 
parameters C, μmax and G obtained from J culture were 
significantly lower (p < 0.05) than the ones corresponding 
to the 11 strain culture for all the assessed techniques but 
for CCU. Indeed, none of the parameters obtained from 
the application of the Gompertz model to the CCU data 
was significantly different between M. hyopneumoniae 
strains.
All Gompertz regression models had  p values lower 
than 0.05 and R2 values between 0.83 and 1. In general 
terms, mean APE values of each strain and technique 
were negative, indicating overall overestimated predic-
tions by the model. Calculated mean APE technique 
values (average from all strain APE within a method) 
are shown in Figure  7. APE associated with prediction 
of M. hyopneumoniae culture titre at each time showed 
that differences between predicted and actual titre values 
alternated in positive and negative sign in all procedures. 
The highest error, however, was observed in the CCU 
method. For all the other assessed techniques.
Relationship between ATP, CCU, fluorimetry and qPCR 
assays
Similar to what happened for the Gompertz model-
ling, the lack of CFU data hampered the comparison of 
this technique with the others. During the exponen-
tial growth phase, there was high correlation (r > 0.9) 
between all the other evaluated methodologies in all 
three M. hyopneumoniae strain cultures and these were 
statistically associated (p < 0.001) (Table 2). Equivalences 
between the assessed methods resulting from the appli-
cation of the formulae from the linear regression analyses 
between each pair of techniques in each strain culture are 
provided in Table 3.
0
5
10
15
20
25
0
2
4
6
8
10
12
0 0.5 1 2 3 4 5 6 7 8 9 10 11 12 13 14
L
og
2(
C
FU
/m
L
)
)
L
m/P
TAlo
mp(2go
L
Days post-inoculation (D)
ATP assay CFU assay
Figure 4 Counts of CFU and ATP concentration per millilitre of M. hyopneumoniae J strain culture. The continuous line represents the counts 
of CFU per millilitre whereas the discontinuous line depicts the ATP concentration per millilitre along the study period.
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Figure 5 Mycoplasma hyopneumoniae strains J (filled triangle), 
11 (filled square) and 232 (filled circle) copies per millilitre of 
dsDNA. Data points represent means of the 2 replicate fluorimetry 
measurements (A and B) within each strain. The orange data points 
indicate when the original medium colour change was first visually 
detected in each strain culture.
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Discussion
In the present study, the course of the in  vitro growth 
of M. hyopneumoniae J, 11 and 232 strains was evalu-
ated by the application of different techniques with the 
potential of being used as an alternative to CCU for M. 
hyopneumoniae culture titration. Growth curve kinetics 
and dynamics of M. hyopneumoniae J strain were differ-
ent from the observed for 11 and 232 strains, which, in 
turn, showed very similar growth curves regardless the 
technique applied. Thus, growth curve plots revealed a 
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Figure 6 Mycoplasma hyopneumoniae strains J (filled triangle), 11 (filled square) and 232 (filled circle) copies per millilitre. Data points 
represent means of the 2 replicate qPCR measurements (A and B) within each strain. The orange data points indicate when the original medium 
colour change was first visually detected in each strain culture.
Table 1 Parameter estimates, coefficient of determination (R2) and average prediction error (APE) for Gompertz model 
used to describe M. hyopneumoniae strains J, 11 and 232 growths 
Different superscripts within a column and technique indicate significant differences between strains (p < 0.05).
a Pmol ATP, CCU or copies of M. hyopneumoniae per mL.
b Pmol ATP, CCU or copies of M. hyopneumoniae per mL per hour per unit of maximal titre (parameter A).
c Pmol ATP, CCU or copies of M. hyopneumoniae per mL per hour.
d Time (hours).
e Percentage (%).
Technique Strain Aa Ba Cb μmax
c Gd R2 APEe
ATP luminometry J 1493.868 10.626 1.065ª 1.171ª 14.607ª 0.981 −5.118
11 1677.066 15.485 1.042b 1.121b 20.317b 0.983 5.423
232 1497.592 15.909 1.056ab 1.159ab 15.756ab 0.985 −3.054
CCU J 1.25E+10 1.47E+02 1.083 1.310 9.536 0.938 −34.413
11 9.58E+09 1.48E+03 1.055 1.205 13.788 0.897 −5.401
232 1.51E+10 5.79E+00 1.026 1.175 14.649 0.829 −70.113
Fluorimetry J 2.18E+08 1.54E+04 1.143ª 1.228ª 11.610ª 0.997 −4.773
11 2.54E+08 1.92E+03 1.079b 1.128b 19.256b 0.991 −2.233
232 1.69E+08 3.23E+04 1.115ab 1.160ab 15.585ab 0.991 −5.161
qPCR J 7.46E+08ab 2.67E+02ab 1.110ª 1.331ª 8.162ª 0.997 0.074
11 8.01E+08ª 2.27E+02ª 1.068b 1.185b 13.597b 0.986 −6.814
232 4.98E+08b 2.17E+04b 1.103ab 1.252ab 10.535ab 0.983 −12.984
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faster in vitro growth of the J strain in comparison with 
11 and 232 strains as well as a straighter log phase, and a 
shorter stationary phase followed by a steeper senescence 
phase. Nonetheless, raw data analysis showed no differ-
ences between strains in terms of maximal titres reached 
within a particular technique.
Results obtained by those methods that indirectly 
measure the number of metabolising cells (i.e. CCU and 
ATP assays) indicated that, once maximal levels were 
reached, CCU titres dropped earlier than the onset of 
decrease in ATP titres. This fact supports that M. hyo-
pneumoniae loses its capacity to divide (requisite for the 
CCU titration) before cell lysis and intracellular ATP 
impairment [13, 27]. Considering ATP growth curves, the 
medium colour change from red to orange was observed 
in the last section of the log phase, whereas the shift to 
yellow was complete in the stationary phase. However, 
when CCU growth curves are taken into account, the 
original red shift to orange happened when all strain cul-
tures were already in the stationary phase. Henceforth, 
M. hyopneumoniae growth phase in which medium turn 
colour may vary depending on different conditions, such 
as the medium itself or even the batch of medium used 
[13], the volume of medium to be judged, as well as on 
the technique used to assess the growth of the bacterium. 
Therefore, extrapolation of the growth phase from the 
colour of the medium should be used with caution. On 
the other hand, both molecular methods (i.e. fluorim-
etry and qPCR assays) led to very similar growth curve 
responses, showing a slightly gradual decrease in the 
copy numbers once reached the stationary phase. This 
finding indicates that DNA fragments might be present 
in culture for longer periods once cells are dead. Hence-
forth, extrapolation of the growth phase from genomic 
copy numbers can also be confounding as no clear dif-
ferentiation could be established between stationary and 
senesce phases.
In the present work, M. hyopneumoniae colonies 
were seen for all three strains assessed. Nevertheless, a 
growth curve based on CFU could only be determined by 
J strain, since growth of 11 and 232 colonies was much 
more limited. These results indicate that solid medium 
might support differently the growth of diverse M. hyo-
pneumoniae strains. Indeed, M. hyopneumoniae  growth 
on solid medium has been considered particularly diffi-
cult [28] and solidification of Friis medium with agar may 
hamper the growth of colonies of  M. hyopneumoniae, 
suggesting that agar inhibits the growth or sequesters 
essential nutrients for growing [29]. In a recently pub-
lished work, however, M. hyopneumoniae growth curve 
could be accurately determined by using viable counts on 
the solid medium [29] and such curve was, actually, simi-
lar in shape to the one obtained for strain J in the pre-
sent study. Strain J culture reached a maximum viability 
of 6.5 × 105 CFU/mL at D6, which approximately corre-
sponded to the medium colour shift to orange as well as 
with the end of the log phase determined by ATP culture 
concentrations. After this point, there was a decline until 
D10, from where no more colonies were observed. For 11 
and 232 strains, colonies appeared when cultures were in 
the stationary phase (data not shown). Although depend-
ing probably on several conditions such as the M. hyo-
pneumoniae strain or the medium used, overall, obtained 
results suggest that the CFU technique underestimates 
the number of live cells, suggesting the inappropriateness 
of this method for M. hyopneumoniae titration.
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Figure 7 Distribution of average prediction error (APE) of M. 
hyopneumoniae titre data from distinct titration techniques. 
APE was defined by the Gompertz model for data obtained from 
the application of ATP luminometry, CCU, fluorimetry and qPCR 
techniques.
Table 2 Correlation between evaluated techniques 
considering data from the logarithmic phase of 
growth (according to ATP luminometry assay) of M. 
hyopneumoniae strain J, 11 and 232 cultures 
All systems were statistically associated (p < 0.001).
Strain Technique
ATP CCU Fluorimetry qPCR
ATP
 J – 0.929 0.930 0.961
 11 – 0.924 0.952 0.966
 232 – 0.950 0.945 0.966
CCU 
 J – – 0.958 0.954
 11 – – 0.985 0.979
 232 – – 0.933 0.925
Fluorimetry
 J – – – 0.982
 11 – – – 0.993
 232 – – – 0.989
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Microbial growth curve is typically depicted in terms 
of log numbers and it has a characteristic sigmoid shape. 
Thus, one way to describe bacteria growth is using non-
linear regression models, such as the Gompertz equation 
[23, 30]. This model accommodates measurements in 
some kinetics parameters and permits appropriate bio-
logical interpretation.  In the present case and based on 
the R2, the Gompertz model was well adjusted to data 
coming from the application of different titration tech-
niques in all three strain cultures, except for the CFU. As 
a reference, former application of the Gompertz model 
to M. hyopneumoniae ATP growth curves resulted also 
in high R2 values [13]. Overall, from the comparison 
between APE values obtained for each technique, the 
Gompertz model had poorer fit during the early than 
at late phases of M. hyopneumoniae growth. In the pre-
sent study, the lack of data at early phases (hours sub-
sequent to the initial inoculum dilution) was perhaps a 
major limitation of this model. Moreover, CCU was the 
worst predicted method by the model, probably because 
progression along time did not always correspond to a 
further dilution turning colour, not showing a typical 
bacteria growth curve.
Information related to the association between the 
in vitro growth and the difference in pathogenicity or vir-
ulence between M. hyopneumoniae strains is scarce and 
can often be difficult to interpret. In fact, the information 
available on such respect is up to now contradictory 
[10–13]. In the present study, estimated kinetic parame-
ters by the Gompertz model confirmed the faster in vitro 
performance of the non-pathogenic J strain observed in 
the growth curve plots. Indeed, all the applied methods 
mostly agreed that J was the fastest growing strain and 
the pathogenic 11 the slowest one. In agreement, M. hyo-
pneumoniae J strain protein expression profile was found 
to be related to metabolism (indicative of a non-infective 
proliferate lifestyle that would fit a better adaptation to 
the in  vitro conditions) whereas proteins expressed by 
pathogenic strains (e.g. 232 strain) were predicted to be 
more associated to the infectious competence [10, 11]. 
This would also agree with the described loss of virulence 
and adhesion capacity due to successive in vitro passages 
[3, 14, 15]. In contradiction to obtained results, a faster 
in  vitro multiplication (determined by the CCU assay) 
was observed in a highly virulent M. hyopneumoniae iso-
late when compared to a low virulent one [12]. Later on, 
however, the same research group studied the course of 
growth of those two isolates, together with other iso-
lates proved to be diverse in virulence [31], genetically 
[32] and phenotypically [33] and did not find association 
between isolates virulence and growth response curves 
assessed by ATP luminometry [13]. Overall results sug-
gest a putative relationship between virulence and the 
in vitro growing capacity of M. hyopneumoniae, although 
Table 3 Values of each evaluated technique corresponding to a unit of a particular method (first column) in each M. 
hyopneumoniae strain culture 
Equivalences were obtained by fitting the linear regression models ofeach pair of techniques comparison to data from the maximal culture growth (log phase).
Technique (one unit) Strain Technique (equivalence units)
ATP (pmol ATP/mL) CCU (CCU/mL) Fluorimetry (M. 
hyopneumoniae 
copies/mL)
qPCR (M. 
hyopneumoniae 
copies/mL)
ATP (pmol ATP/mL) J – 1.76E+05 6.09E+05 6.40E+04
11 – 4.05E+05 1.23E+06 2.09E+05
232 – 1.66E+03 1.08E+06 1.71E+05
Mean (± SD) – 1.94E+05 (± 2.02E+05) 9.72E+05 (± 3.23E+05) 1.48E+05 (± 7.51E+04)
CCU (CCU/mL) J 2.10E−04 – 9.68E+02 3.79E+00
11 3.92E−05 – 1.02E+03 4.65E+00
232 1.23E−02 – 7.79E+04 3.77E+03
Mean (± SD) 4.17E−03 (± 7.00E−03) – 2.66E+04 (± 4.44E+04) 1.26E+03 (± 2.17E+03)
Fluorimetry (M. hyopneumoniae 
copies/mL)
J 7.99E−08 < 1 – < 1
11 6.47E−09 < 1 – < 1
232 1.53E−09 < 1 – < 1
Mean (± SD) 2.93E−08 (± 4.39E−08) NA – NA
qPCR (M. hyopneumoniae copies/
mL)
J 2.12E−04 < 1 3.50E+02 –
11 2.51E−05 < 1 3.69E+02 –
232 1.18E−05 <  1 3.20E+02 –
Mean (± SD) 8.30E−05 (± 1.12E−04) NA 3.47E+02 (± 2.49E+01) –
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further studies are needed to confirm results and rein-
force this hypothesis.
Although reasons for the former inconsistencies are 
difficult to elucidate, some aspects should be kept in 
mind. First, the growth medium has been reported to 
have a more pronounced effect on the M. hyopneumo-
niae growth response than the isolate by itself [13]. Sec-
ond, comparisons of the course of growth of different M. 
hyopneumoniae are hindered by the inherent difficulty in 
obtaining strain initial inoculum with the same amount 
of M. hyopneumoniae live cells. In the present case, all 
strain initial inoculum came from single colonies and 
were used when reached similar maximal ATP values. 
Moreover, such inocula were equally diluted at D0 and 
volumes taken at every time point were the same for all 
strain cultures. The abovementioned aspects may also 
partly explain the differences found in the kinetics of 
the growth curves between this work and a previous one 
[13]. While the initial ATP and CCU concentrations were 
fairly similar between both studies, the former reported 
growth curves were much shorter in time than the ones 
reported in here. Although other many growing condi-
tions might be implicated in such differences, this finding 
highlights again the effect that the use of different culture 
media may have on M. hyopneumoniae in vitro growth. 
Besides dissimilarities, it is important to note that pre-
vious estimated maximum ATP titres reached values of 
1350  pmol ATP/mL [13], which were not distant from 
the maximum values appraised in this work of 1689 pmol 
ATP/mL.
Comparison of results obtained by the differ-
ent applied techniques was an important part of the 
present study. During the log growth phase, titra-
tion results of the four assays were highly and signifi-
cantly correlated and a strong linear relationship was 
observed. Ideally, further M. hyopneumoniae strains as 
well as culturing time points should be included to bet-
ter assess the relationship between techniques. Never-
theless, growth kinetics of 7 diverse M. hyopneumoniae 
isolates were previously judged and, in agreement with 
the present results, CCU and ATP titres were strongly 
linearly linked during log phase [13]. According to 
the assessed regression models, M. hyopneumoniae 
culture had a mean ATP content of 4.17 × 10−3 pmol 
per colour change of 1  mL culture, whereas another 
study reported M. hyopneumoniae  culture to contain 
1.77 × 10−6 pmol ATP per CCU in 1  mL of culture 
[13]. Henceforth, in the present work, a higher amount 
of ATP was needed in comparison to the previous 
one to achieve the change of colour of 1  mL culture, 
which may partly explain the different lengths between 
growth curves of both studies. Neither CCU, ATP nor 
fluorimetry assays are specific for M. hyopneumoniae, 
which might be problematic when other inoculum type 
rather than culture is used (e.g. lung homogenate). In 
this case, M. hyopneumoniae copies per mL assessed 
by qPCR may be the most approximated value to the 
number of M. hyopneumoniae cells. The amount of M. 
hyopneumoniae DNA determined by qPCR revealed 
that 1 CCU/mL correspond to 1260 mycoplasmas. This 
value is close to previous data reporting that 1 CCU/
mL of M. hyopneumoniae strain 116 corresponded to 
1000 mycoplasmas [20]. While qPCR might be a reli-
able titration technique during the M. hyopneumoniae 
log growing phase, its inability to differentiate between 
alive and dead cells is a major disadvantage during the 
later stages of the growth. Given that each of the evalu-
ated titration methodologies have limitations, their use 
in combination is probably required to optimise M. 
hyopneumoniae culture titration accuracy.
In order to standardize M. hyopneumoniae growth 
protocols in the laboratory as well as inoculum pro-
duction for experimental applications, it is important 
to know the in  vitro  growth kinetics and dynamics of 
a particular strain in a particular medium. Once this 
information is known, a more reliable approxima-
tion of the growing phase status from the culture col-
our change can be performed. For this purpose, ATP 
is an economical, rapid, timely and efficient assay that 
allows the distinction of the different M. hyopneumo-
niae growing phases in culture. Nonetheless, ATP is 
not a M. hyopneumoniae specific technique; thus, its 
combination with a specific detection method (such 
the qPCR) might be useful. Lastly, further studies with 
more strains, both at in  vitro and in  vivo levels, are 
needed to elucidate the putative relationship between 
M. hyopneumoniae in vitro behaviour and virulence.
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